Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial.

待确认 10 由 Aixuexi 发布于 2026/8/3 16:01:17

DOI:10.1016/j.medj.2026.101029
作者：Fei Han,?Xing Lv,?Yu-Juan Zhou,?Qian He,?Ye Guo,?Yan-Qun Xiang,?Xiao-Lei Shu,?Su-Ming Pan,?Shen-Hong Qu,?Peng Zhang,?Yi Jiang,?Ming-Jun Xu,?Kai-Jian Lei,?Song Qu,?Xiao-Hui Wang,?Yong-Shuai Jin,?Bei Zh
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Background: Recurrent/metastatic (R/M) nasopharyngeal carcinoma (NPC) patients who failed platinum-based chemotherapy, with or without PD-1/L1 inhibitors, face limited treatment options. We

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

3小时前

ming18

e9642cb68f1211f1906234735aa3bc31.pdf

3小时前

Book学术机器人

2026/8/3 16:01:18 未找到该文献，机器人已退出，请等待人工下载

2026/8/3 16:01:17 Book学术AI机器人收到请求，开始寻找文献

2026/8/3 16:01:17 已向机器人发送请求

3小时前

Aixuexi 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Royal Society of Chemistry (RSC)Efficient construction of hard carbon through hydrothermal carbon coating engineering toward enhanced sodium–ion storage performance